1. Home
  2. ASTSW vs TNGX Comparison

ASTSW vs TNGX Comparison

Compare ASTSW & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASTSW
  • TNGX
  • Stock Information
  • Founded
  • ASTSW N/A
  • TNGX 2014
  • Country
  • ASTSW United States
  • TNGX United States
  • Employees
  • ASTSW 489
  • TNGX N/A
  • Industry
  • ASTSW Telecommunications Equipment
  • TNGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASTSW Consumer Discretionary
  • TNGX Health Care
  • Exchange
  • ASTSW Nasdaq
  • TNGX Nasdaq
  • Market Cap
  • ASTSW N/A
  • TNGX 990.5M
  • IPO Year
  • ASTSW 2019
  • TNGX N/A
  • Fundamental
  • Price
  • ASTSW $5.41
  • TNGX $9.91
  • Analyst Decision
  • ASTSW
  • TNGX Strong Buy
  • Analyst Count
  • ASTSW 0
  • TNGX 8
  • Target Price
  • ASTSW N/A
  • TNGX $14.86
  • AVG Volume (30 Days)
  • ASTSW N/A
  • TNGX 877.3K
  • Earning Date
  • ASTSW N/A
  • TNGX 08-05-2024
  • Dividend Yield
  • ASTSW N/A
  • TNGX N/A
  • EPS Growth
  • ASTSW N/A
  • TNGX N/A
  • EPS
  • ASTSW N/A
  • TNGX N/A
  • Revenue
  • ASTSW N/A
  • TNGX $37,232,000.00
  • Revenue This Year
  • ASTSW N/A
  • TNGX N/A
  • Revenue Next Year
  • ASTSW N/A
  • TNGX $2.40
  • P/E Ratio
  • ASTSW N/A
  • TNGX N/A
  • Revenue Growth
  • ASTSW N/A
  • TNGX 49.72
  • 52 Week Low
  • ASTSW N/A
  • TNGX $2.88
  • 52 Week High
  • ASTSW N/A
  • TNGX $13.03
  • Technical
  • Relative Strength Index (RSI)
  • ASTSW N/A
  • TNGX 58.89
  • Support Level
  • ASTSW N/A
  • TNGX $8.93
  • Resistance Level
  • ASTSW N/A
  • TNGX $9.96
  • Average True Range (ATR)
  • ASTSW 0.00
  • TNGX 0.61
  • MACD
  • ASTSW 0.00
  • TNGX -0.01
  • Stochastic Oscillator
  • ASTSW 0.00
  • TNGX 88.78

About ASTSW AST SpaceMobile Inc. Warrant

AST SpaceMobile Inc is a satellite designer and manufacturer. The company is building a cellular broadband network in space to operate directly with standard, unmodified mobile devices, and off-the-shelf mobile phones based on extensive IP and patent portfolio. It has focused on eliminating the connectivity gaps faced by mobile subscribers and finally bringing broadband to the billions who remain unconnected. The Company's spaceMobile Service is being designed to provide cost-effective, high-speed Cellular Broadband services to end-users who are out of terrestrial cellular coverage using existing mobile devices.

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

Share on Social Networks: